13
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      White matter hyperintensities at critical crossroads for executive function and verbal abilities in small vessel disease

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          The presence of white matter lesions in patients with cerebral small vessel disease (SVD) is among the main causes of cognitive decline. We investigated the relation between white matter hyperintensity (WMH) locations and executive and language abilities in 442 SVD patients without dementia with varying burden of WMH. We used Stroop Word Reading, Stroop Color Naming, Stroop Color‐Word Naming, and Category Fluency as language measures with varying degrees of executive demands. The Symbol Digit Modalities Test (SDMT) was used as a control task, as it measures processing speed without requiring language use or verbal output. A voxel‐based lesion–symptom mapping (VLSM) approach was used, corrected for age, sex, education, and lesion volume. VLSM analyses revealed statistically significant clusters for tests requiring language use, but not for SDMT. Worse scores on all tests were associated with WMH in forceps minor, thalamic radiations and caudate nuclei. In conclusion, an association was found between WMH in a core frontostriatal network and executive‐verbal abilities in SVD, independent of lesion volume and processing speed. This circuitry underlying executive‐language functioning might be of potential clinical importance for elderly with SVD. More detailed language testing is required in future research to elucidate the nature of language production difficulties in SVD.

          Abstract

          The manuscript describes a study of the relation between white matter hyperintensity (WMH) locations and executive and language abilities in small vessel disease patients without dementia with varying burden of WMH.

          Related collections

          Most cited references55

          • Record: found
          • Abstract: found
          • Article: found

          Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration

          Summary Cerebral small vessel disease (SVD) is a common accompaniment of ageing. Features seen on neuroimaging include recent small subcortical infarcts, lacunes, white matter hyperintensities, perivascular spaces, microbleeds, and brain atrophy. SVD can present as a stroke or cognitive decline, or can have few or no symptoms. SVD frequently coexists with neurodegenerative disease, and can exacerbate cognitive deficits, physical disabilities, and other symptoms of neurodegeneration. Terminology and definitions for imaging the features of SVD vary widely, which is also true for protocols for image acquisition and image analysis. This lack of consistency hampers progress in identifying the contribution of SVD to the pathophysiology and clinical features of common neurodegenerative diseases. We are an international working group from the Centres of Excellence in Neurodegeneration. We completed a structured process to develop definitions and imaging standards for markers and consequences of SVD. We aimed to achieve the following: first, to provide a common advisory about terms and definitions for features visible on MRI; second, to suggest minimum standards for image acquisition and analysis; third, to agree on standards for scientific reporting of changes related to SVD on neuroimaging; and fourth, to review emerging imaging methods for detection and quantification of preclinical manifestations of SVD. Our findings and recommendations apply to research studies, and can be used in the clinical setting to standardise image interpretation, acquisition, and reporting. This Position Paper summarises the main outcomes of this international effort to provide the STandards for ReportIng Vascular changes on nEuroimaging (STRIVE).
            Bookmark
            • Record: found
            • Abstract: not found
            • Article: not found

            Improved Optimization for the Robust and Accurate Linear Registration and Motion Correction of Brain Images

              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Cerebral small vessel disease: from pathogenesis and clinical characteristics to therapeutic challenges.

              The term cerebral small vessel disease refers to a group of pathological processes with various aetiologies that affect the small arteries, arterioles, venules, and capillaries of the brain. Age-related and hypertension-related small vessel diseases and cerebral amyloid angiopathy are the most common forms. The consequences of small vessel disease on the brain parenchyma are mainly lesions located in the subcortical structures such as lacunar infarcts, white matter lesions, large haemorrhages, and microbleeds. Because lacunar infarcts and white matter lesions are easily detected by neuroimaging, whereas small vessels are not, the term small vessel disease is frequently used to describe the parenchyma lesions rather than the underlying small vessel alterations. This classification, however, restricts the definition of small vessel disease to ischaemic lesions and might be misleading. Small vessel disease has an important role in cerebrovascular disease and is a leading cause of cognitive decline and functional loss in the elderly. Small vessel disease should be a main target for preventive and treatment strategies, but all types of presentation and complications should be taken into account. Copyright 2010 Elsevier Ltd. All rights reserved.
                Bookmark

                Author and article information

                Contributors
                i.camerino@donders.ru.nl
                Journal
                Hum Brain Mapp
                Hum Brain Mapp
                10.1002/(ISSN)1097-0193
                HBM
                Human Brain Mapping
                John Wiley & Sons, Inc. (Hoboken, USA )
                1065-9471
                1097-0193
                24 November 2020
                March 2021
                : 42
                : 4 ( doiID: 10.1002/hbm.v42.4 )
                : 993-1002
                Affiliations
                [ 1 ] Donders Institute for Brain, Cognition, and Behaviour, Donders Centre for Cognition Radboud University Nijmegen The Netherlands
                [ 2 ] Donders Institute for Brain, Cognition and Behaviour, Donders Centre for Medical Neuroscience, Department of Medical Psychology Radboud University Medical Center Nijmegen The Netherlands
                [ 3 ] Donders Institute for Brain, Cognition and Behaviour, Centre for Neuroscience, Department of Neurology Radboud University Nijmegen The Netherlands
                [ 4 ] School of Psychology University of Nottingham Nottingham UK
                [ 5 ] Center for Neuroprosthetics (CNP) and Brain Mind Institute (BMI) École Polytechnique Fédérale de Lausanne Lausanne Switzerland
                Author notes
                [*] [* ] Correspondence

                Ileana Camerino, Donders Institute for Brain, Cognition, and Behaviour, Donders Centre for Cognition, Radboud University, Montessorilaan 3, 6525 HR Nijmegen, The Netherlands.

                Email: i.camerino@ 123456donders.ru.nl

                Author information
                https://orcid.org/0000-0002-7312-9329
                https://orcid.org/0000-0002-5991-6916
                https://orcid.org/0000-0002-4815-2834
                https://orcid.org/0000-0001-9500-9793
                https://orcid.org/0000-0003-2221-3026
                https://orcid.org/0000-0002-4860-5952
                Article
                HBM25273
                10.1002/hbm.25273
                7856651
                33231360
                dbc41e60-c992-476c-8669-aedda924c7cd
                © 2020 The Authors. Human Brain Mapping published by Wiley Periodicals LLC.

                This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.

                History
                : 28 July 2020
                : 30 September 2020
                : 22 October 2020
                Page count
                Figures: 4, Tables: 3, Pages: 10, Words: 8220
                Funding
                Funded by: Netherlands Organization for Scientific Research
                Award ID: 024.001.006
                Award ID: 451‐17‐003
                Funded by: Dutch Heart Foundation , open-funder-registry 10.13039/501100002996;
                Award ID: 2016 T044
                Award ID: 2014 T060
                Funded by: Innovational Research Incentive
                Award ID: 016‐126‐351
                Categories
                Research Article
                Research Articles
                Custom metadata
                2.0
                March 2021
                Converter:WILEY_ML3GV2_TO_JATSPMC version:5.9.7 mode:remove_FC converted:03.02.2021

                Neurology
                cerebral small vessel diseases,executive functions,language,leukoaraiosis,magnetic resonance imaging,verbal abilities,voxel‐based lesion–symptom mapping,white matter hyperintensities

                Comments

                Comment on this article